相似文献
1
Biomarker-guided therapy for heart failure.
Indian Heart J. 2012 Mar-Apr;64(2):178-81. doi: 10.1016/S0019-4832(12)60057-1. Epub 2012 Apr 28.
2
Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure.
Respirology. 2013 Apr;18(3):540-5. doi: 10.1111/resp.12039.
3
An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure.
Scand J Clin Lab Invest. 1998 Dec;58(8):683-91. doi: 10.1080/00365519850186120.
4
Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides.
Heart Fail Clin. 2018 Jan;14(1):13-25. doi: 10.1016/j.hfc.2017.08.002.
5
The roles of natriuretic peptides in pericardial fluid in patients with heart failure.
Clin Cardiol. 2009 Mar;32(3):159-63. doi: 10.1002/clc.20306.
6
Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
PLoS One. 2015 Aug 5;10(8):e0134376. doi: 10.1371/journal.pone.0134376. eCollection 2015.
7
NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Circulation. 2018 Apr 17;137(16):1671-1683. doi: 10.1161/CIRCULATIONAHA.117.029882. Epub 2017 Dec 14.
8
Fall in readmission rate for heart failure after implementation of B-type natriuretic peptide testing for discharge decision: a retrospective study.
Int J Cardiol. 2008 Jun 6;126(3):400-6. doi: 10.1016/j.ijcard.2006.03.097. Epub 2007 Sep 4.
9
Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure.
Am J Med. 2002 Aug 15;113(3):215-9. doi: 10.1016/s0002-9343(02)01184-1.
10
Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
Am Heart J. 2009 Sep;158(3):422-30. doi: 10.1016/j.ahj.2009.06.018. Epub 2009 Jul 9.
本文引用的文献
1
Biomonitoring and biomarker-guided therapy: the next step in heart failure and biomarker research.
J Am Coll Cardiol. 2011 Oct 25;58(18):1890-2. doi: 10.1016/j.jacc.2011.07.032.
2
Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction.
J Am Coll Cardiol. 2011 Oct 25;58(18):1881-9. doi: 10.1016/j.jacc.2011.03.072.
3
Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure.
Eur J Heart Fail. 2011 Jan;13(1):37-42. doi: 10.1093/eurjhf/hfq210. Epub 2010 Dec 13.
4
Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study.
J Am Coll Cardiol. 2010 Dec 14;56(25):2090-100. doi: 10.1016/j.jacc.2010.07.030.
5
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
J Am Coll Cardiol. 2010 May 11;55(19):2062-76. doi: 10.1016/j.jacc.2010.02.025.
6
N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.
J Am Coll Cardiol. 2009 Dec 29;55(1):53-60. doi: 10.1016/j.jacc.2009.02.095.
7
Biomarker guided therapy for heart failure: focus on natriuretic peptides.
Heart Fail Rev. 2010 Jul;15(4):351-70. doi: 10.1007/s10741-009-9139-9.
8
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
JAMA. 2009 Jan 28;301(4):383-92. doi: 10.1001/jama.2009.2.
9
Cardiac troponin and outcome in acute heart failure.
N Engl J Med. 2008 May 15;358(20):2117-26. doi: 10.1056/NEJMoa0706824.
10
Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE.
Am J Cardiol. 2008 Jan 15;101(2):231-7. doi: 10.1016/j.amjcard.2007.07.066. Epub 2007 Dec 3.
Zotero 插件